Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Vland Biotech Group is a leading Chinese biotechnology company specializing in the research, development, and production of enzymes, probiotics, and animal health products. The company serves a diverse array of industries, including agriculture, animal husbandry, food processing, textiles, and environmental protection. Vland utilizes advanced technology platforms in microbial fermentation, protein engineering, and high-throughput screening to create sustainable biological solutions. Their product portfolio includes high-efficiency feed enzymes, industrial enzymes for textile and paper processing, and specialized probiotic strains for both animal and human health. The group maintains significant global partnerships, most notably a joint venture with ADM focused on the human nutrition and probiotic markets. Headquartered in Qingdao and listed on the Shanghai Stock Exchange, Vland is recognized as a key player in China's industrial biotech sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Vland Biotech Group.